Hemodynamics, fluids & transfusion

Intrinsic or Nonintrinsic End-stage Liver Disease and Its Association With Thromboelastography-based Coagulation States in Patients Undergoing Liver Transplantation: A Retrospective Cohort Study

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Authors' conclusion

Liver transplantation candidates with intrinsic liver disease tend to exhibit hypocoagulable TEG patterns, while nonintrinsic disease is associated with hypercoagulability.

Study context

Population
Adult liver transplant patients, single quaternary care hospital
Participants
1,078 patients
Exposure
Intrinsic vs nonintrinsic end-stage liver disease
Outcome
TEG patterns (hypocoagulable, mixed) by etiology of end-stage liver disease
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Hypocoagulable and mixed TEG patterns
Intrinsic vs NonintrinsicOdds ratio (95% CI)P value
Hypocoagulable pattern
3.70(1.94–7.07)
P < 0.0001
Mixed pattern
4.59(2.07–10.16)
P = 0.0002

Observational data: associations, not effects.

Further findings

Increasing MELD score and thromboelastography (TEG) patterns

OR (95% CI)P value
Increasing MELDHypocoagulable pattern1.14 (1.08–1.19)P < 0.0001
Increasing MELDMixed pattern1.08 (1.03–1.14)P = 0.0036

Child-Pugh class C and TEG patterns

OR (95% CI)P value
Child-Pugh CHypocoagulable pattern8.55 (3.26–22.42)P < 0.0001
Child-Pugh CMixed pattern12.48 (3.89–40.03)P < 0.0001

Major preoperative thrombotic complications and TEG patterns

Not associated with specific TEG patterns; interaction with liver disease severity observed

Original publication

Intrinsic or Nonintrinsic End-stage Liver Disease and Its Association With Thromboelastography-based Coagulation States in Patients Undergoing Liver Transplantation: A Retrospective Cohort Study. J Cardiothorac Vasc Anesth. Published 23 July 2024. doi:10.1053/j.jvca.2024.07.036

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.